Stay updated on EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer

Sign up to get notified when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.
Latest website image capture
Clouds background image

Latest updates to the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:44:39.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study record of a Phase III clinical trial evaluating the efficacy and safety of MEDI4736 + tremelimumab combination therapy and MEDI4736 monotherapy versus standard of care therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:08.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age, consent, and health conditions required for inclusion, as well as conditions for exclusion.
    Difference
    17%
    Check dated 2024-05-22T21:11:29.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:47:40.000Z thumbnail image

Stay in the know with updates to EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer

Enter your email address, and we'll notify you when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.